tiprankstipranks

Stephen Davis Insider Profile

11 Followers
Stephen Davis, CEO, Director at ACADIA Pharmaceuticals, holds 144.27K shares in ACADIA Pharmaceuticals (Ticker: ACAD), holds 52.03K shares in Heron Therapeutics (Ticker: HRTX), holds 0.00 shares in Synageva (Ticker: GEVA).
tipranks
Stephen Davis

Stephen Davis
ACADIA Pharmaceuticals (ACAD)
CEO, Director

Ranked #21,385 out of 98,564 Corporate Insiders

Profitable Transactions

100%
3 out of 3 Profitable Transactions

Average Return

+31.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$3M
94.31%
5.69%
A breakdown of Stephen Davis's holdings

Insider Roles

ACADIA Pharmaceuticals
(ACAD)
CEO, Director
Heron Therapeutics
(HRTX)
Director
Roles that Stephen Davis holds in companies

Most Profitable Insider Trade

Stock:
ACADIA Pharmaceuticals
(ACAD)
Rating:Informative Sell
Date:Jan 09, 2024 - Today
Return:+45.10%
The most profitable trade made by Stephen Davis

Stephen Davis's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
ACADIA Pharmaceuticals
Apr 09, 2024
CEO, Director
Uninformative Sell
474.88K
$2.42M
Heron Therapeutics
Dec 20, 2022
Director
Uninformative Buy
$145.69K
GEVA
Synageva
BLCM
Bellicum Pharmaceuticals
Jan 06, 2022
Uninformative Buy
$10.13K
FURX
Furiex Pharmaceuticals
Mar 04, 2014
Uninformative Buy
List of latest transactions for each holding click on a transaction to see Stephen Davis's performance on stock

Stephen Davis insider profile FAQ

What is the percentage of profitable transactions made by Stephen Davis?
The percentage of profitable transactions made by Stephen Davis is 100%.
    What is the average return per transaction made by Stephen Davis?
    The average return per transaction made by Stephen Davis is 31.20%.
      What stocks does Stephen Davis hold?
      Stephen Davis holds: ACAD, HRTX, GEVA, BLCM, FURX stocks.
        What was Stephen Davis’s latest transaction?
        Stephen Davis latest transaction was an Uninformative Sell of $474.88K.
          What was Stephen Davis's most profitable transaction?
          Stephen Davis’s most profitable transaction was an Informative Sell of ACAD stock on January 9, 2024. The return on the trade was 45.10%.
            What is Stephen Davis's role in ACADIA Pharmaceuticals?
            Stephen Davis's role in ACADIA Pharmaceuticals is CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.